Enzo Biochem, Inc. (ENZ) financial statements (2021 and earlier)

Company profile

Business Address 60 EXECUTIVE BLVD
FARMINGDALE, NY 11735
State of Incorp. NY
Fiscal Year End July 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

1/31/2021
TTM
7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45486060646818
Cash and cash equivalents45486060646818
Receivables1291113151519
Inventory, net of allowances, customer advances and progress billings9887777
Inventory9887777
Prepaid expense4433322
Total current assets:70698183899146
Noncurrent Assets
Operating lease, right-of-use asset1820 
Property, plant and equipment1414148888
Intangible assets, net (including goodwill)8889101214
Goodwill7777777
Intangible assets, net (excluding goodwill)0112346
Regulated entity, other noncurrent assets      0
Other noncurrent assets1121000
Other undisclosed noncurrent assets      (0)
Total noncurrent assets:42442518192022
TOTAL ASSETS:11211310710210811268
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19211620171824
Accounts payable4971010109
Accrued liabilities15138107811
Employee-related liabilities      4
Debt77  (0)(1)(0)
Estimated litigation liability      10
Self insurance reserve    000
Other liabilities0001111
Other undisclosed current liabilities44  02(11)
Total current liabilities:30331620182124
Noncurrent Liabilities
Long-term debt and lease obligation20214   1
Long-term debt, excluding current maturities444   0
Capital lease obligations   0
Operating lease, liability1617 
Liabilities, other than long-term debt0000122
Deferred tax liabilities, net   0
Other liabilities0000122
Other undisclosed noncurrent liabilities      (1)
Total noncurrent liabilities:202150122
Total liabilities:50542121192226
Stockholders' equity
Stockholders' equity attributable to parent62588681899043
Common stock0000000
Additional paid in capital336334333331328326325
Accumulated other comprehensive income1232222
Accumulated deficit(276)(278)(250)(252)(242)(239)(285)
Total stockholders' equity:62588681899043
TOTAL LIABILITIES AND EQUITY:11211310710210811268

Income statement (P&L) ($ in millions)

1/31/2021
TTM
7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
Revenues97768110510810398
Revenue, net10810398
Cost of revenue(57)(52)(60) (59)(57)(55)
Cost of goods and services sold(57)(52)(58) (59)(57)(55)
Gross profit:402421105484643
Operating expenses(52)(54)(19)(56)(51)8(37)
Other undisclosed operating loss   (60) (6)(7)
Operating income (loss):(12)(30)2(12)(3)47(1)
Nonoperating income (expense)11111(0)(1)
Investment income, nonoperating  110(0)(0)
Foreign currency transaction gain (loss), before tax11(1)(0)0(0)(1)
Other nonoperating income0000000
Interest and debt expense(0)(0)     
Other undisclosed income from continuing operations before equity method investments, income taxes00     
Income (loss) from continuing operations before equity method investments, income taxes:(10)(29)2(11)(2)47(2)
Other undisclosed loss from continuing operations before income taxes(0)      
Income (loss) from continuing operations before income taxes:(11)(29)2(11)(2)47(2)
Income tax expense (benefit)   1(0)(1)0
Net income (loss):(11)(29)2(10)(3)45(2)
Other undisclosed net loss attributable to parent(0)      
Net income (loss) available to common stockholders, diluted:(11)(29)2(10)(3)45(2)

Comprehensive Income ($ in millions)

1/31/2021
TTM
7/31/2020
7/31/2019
7/31/2018
7/31/2017
7/31/2016
7/31/2015
Net income (loss):(11)(29)2(10)(3)45(2)
Comprehensive income (loss):(11)(29)2(10)(3)45(2)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(1)00(0)00
Comprehensive income (loss), net of tax, attributable to parent:(12)(29)3(10)(3)46(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: